sunitinib-resistant FLT3 mutants don't bind sunitinib

Stable Identifier
R-HSA-9702629
Type
Reaction [transition]
Species
Homo sapiens
Compartment
plasma membrane
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
sunitinib-resistant FLT3 mutants don't bind sunitinib
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The following FLT3 mutants are resistant to inhibition by sunitinib:

FLT3 A848P (Albers et al, 2013)
FLT3 D835A (Nguyen et al, 2017)
FLT3 D835G (Nguyen et al, 2017)
FLT3 D835N (Nguyen et al, 2017)
FLT3 D835H (partial: Baker et al, 2013)
FLT3 D835Y (partial: Baker et al, 2013; Nguyen et al, 2017)
FLT3 D835A (Nguyen et al, 2017)
Literature References
PubMed ID Title Journal Year
23392356 The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

Yu, C, Albers, C, Verbeek, M, Duyster, J, Leischner, H, Illert, AL, von Bubnoff, N, Peschel, C

Leukemia 2013
Participants
Input
Participates
as an event of
Normal reaction
FLT3 binds type II TKI (Homo sapiens)
Functional status

Loss of function of sunitinib-resistant FLT3 mutants [plasma membrane]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Authored
Rothfels, K  (2020-11-06)
Reviewed
Kazi, JU  (2020-11-06)
Created
Rothfels, K  (2020-10-01)
Cite Us!